Earlier this month, Swiss-based contract development and manufacturing organization (CDMO) ten23 health announced GMP certification to manufacture advanced therapy medicinal products (ATMPs).
The CPHI Sustainability Summit will bring together 300+ pharma leaders Oct. 6–7 in Milan to tackle sustainable manufacturing ...
CASTL partners with Ireland's NIBRT to provide accredited biomanufacturing training, addressing Canada's skilled worker ...
Industry experts at Cell Summit 2026 say the public lacks understanding of biologics and growing distrust poses challenges ...
Ralph Brandenberger of Dark Horse Consulting Group told delegates at the Cell Summit that insufficient planning causes delays ...
BPI Contributor Jeisa Pelet ...
Abu Sadat Muhammod Saiyem, BPI contributor ...
Industrial manufacturing of recombinant therapeutic proteins using Chinese hamster ovary (CHO) cells is a process dominated by multiple levels of selection, such as selection of the right therapeutic ...
With the excitement of the BIO International Convention behind us and with Biotech Week Boston (BWB) a few months away, it’s as good a time as any to reflect upon the first half of 2026. Many ...
The US Food and Drug Administration (FDA) has published a draft guidance to inform gene therapy developers how they can use prior knowledge to accelerate drug development. The draft is not yet ...
Chimeric antigen receptor (CAR) T-cells are one of the most promising new therapy areas against disease, showing significant advances in the treatment of hematological cancers. However, despite six ...
Reducing the Guesswork: Increasing Predictability in CHO Cell Line Development An expert in upstream operations highlights bottlenecks in current cell-line development workflows and explains how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results